Vimarsana
Biggest News Aggregation in the World

Page 10 - Appropriate Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Appropriate Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Appropriate Use Today - Breaking & Trending Today

Key NEPA-GHG Issues For The Biden-Harris Administration: Focus On FERC Chairman Glick And Incoming CEQ Chair Mallory - Environment - Vimarsana News

Key NEPA-GHG Issues For The Biden-Harris Administration: Focus On FERC Chairman Glick And Incoming CEQ Chair Mallory - Environment

To print this article, all you need is to be registered or login on Mondaq.com. In the coming weeks, the Council on Environmental Quality (CEQ) will reveal its plan for revising the National Environmental Policy Act (NEPA) regulations and guidance for analyzing greenhouse gas (GHG) emissions. Indeed, this will be one of the highest priority items for incoming CEQ Chair, Brenda Mallory, who was just confirmed by the Senate in a 53 to 45 vote on April 14, 2021. In the meantime, under the leadership of new Chair Richard Glick, the Federal Energy Regulatory Commission (FER...

Source: mondaq.com
Magnetic Resonance (MR) Receive-only Coil - Performance Criteria for Safety and Performance Based Pathway - Vimarsana News

Magnetic Resonance (MR) Receive-only Coil - Performance Criteria for Safety and Performance Based Pathway

Center for Devices and Radiological Health This guidance provides performance criteria for magnetic resonance (MR) receive-only coils in support of the Safety and Performance Based Pathway. Under this framework, submitters (you) planning to submit a 510(k) using the Safety and Performance Based Pathway for MR receive-only coils will have the option to use the performance criteria proposed in this guidance to support substantial equivalence, rather than a direct comparison of the performance of the subject device to that of a predicate device. Submit Comments

Source: fda.gov